Alta, Rowena O.

HRN: 18-43-49  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2025
CEFTAZIDIME 1GM (VIAL)
05/28/2025
06/03/2025
IV
2g
Q8h
CAPMR
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: No  Wrong Choice  Reserved For Pseudomonas Coverage And Not Routinely Used For Moderate Risk CAP

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: